Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
FURESTEM-RA Inj.
BIOLOGICAL
2 trials
Sponsors
Kang Stem Biotech Co., Ltd.
Conditions
Rheumatoid Arthritis
Phase 1
Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA)
Completed
NCT02221258
Kang Stem Biotech Co., Ltd.
Rheumatoid Arthritis
Start: 2014-10-31
End: 2015-10-31
Updated: 2016-10-06
Unknown Phase
Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj
NCT03106259
Kang Stem Biotech Co., Ltd.
Rheumatoid Arthritis
Start: 2016-06-29
End: 2021-03-21
Updated: 2018-02-09